| Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries JC Bélisle-Pipon, E Vayena, R C. Green, IG Cohen Nature Medicine, 2019 | 56 | 2019 |
| Patients as Research Partners; How to Value their Perceptions, Contribution and Labor? E Smith, JC Bélisle-Pipon, D Resnik Citizen Science 4 (1), 1-13, 2019 | 44 | 2019 |
| Early-career researchers’ views on ethical dimensions of patient engagement in research JC Bélisle-Pipon, G Rouleau, S Birko BMC medical ethics 19, 1-10, 2018 | 37 | 2018 |
| Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information JC Bélisle Pipon, B Williams-Jones Journal of Bioethical Inquiry 12 (2), 259-267, 2015 | 21 | 2015 |
| Duty to inform and informed consent in diagnostic radiology: how ethics and law can better guide practice V Doudenkova, JC Bélisle Pipon Hec Forum 28 (1), 75-94, 2016 | 16 | 2016 |
| What makes artificial intelligence exceptional in health technology assessment? JC Bélisle-Pipon, V Couture, MC Roy, I Ganache, M Goetghebeur, ... Frontiers in Artificial Intelligence, 153, 2021 | 15 | 2021 |
| Merging arts and bioethics: An interdisciplinary experiment in cultural and scientific mediation V Couture, JC Bélisle-Pipon, M Cloutier, C Barnabé Bioethics, 616–630, 2017 | 12 | 2017 |
| Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly’s Canadian 40over40 Erectile Dysfunction Campaign JC Bélisle Pipon, B Williams-Jones Healthcare Policy 10 (4), 16-22, 2015 | 12 | 2015 |
| Early career researchers’ perspectives and roles in patient-oriented research G Rouleau, JC Bélisle-Pipon, S Birko, P Karazivan, N Fernandez, ... Research involvement and engagement 4 (1), 1-15, 2018 | 11 | 2018 |
| Artificial intelligence ethics has a black box problem JC Bélisle-Pipon, E Monteferrante, MC Roy, V Couture AI & Society, 2022 | 9 | 2022 |
| Conflicts of interest and the (in)dependence of experts advising government on immunization policies JC Bélisle-Pipon, L Ringuette, AI Cloutier, V Doudenkova, ... Vaccine, 2018 | 8 | 2018 |
| Ethics education in public health: where are we now and where are we going? V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ... International Journal of Ethics Education, 2017 | 8 | 2017 |
| Preparing for the arrival of “pink Viagra”: strengthening Canadian direct-to-consumer information regulations JC Bélisle Pipon, B Williams-Jones Canadian Medical Association Journal 188 (5), 319-320, 2016 | 7* | 2016 |
| Protecting public health or commercial interests? The importance of transparency during immunization campaigns JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones Ethics, Medicine and Public Health, 2017 | 6 | 2017 |
| De la binarité au modèle AI3R : la bioéthique écosystémique comme modèle d’analyse normative de l’industrie biopharmaceutique JC Bélisle Pipon Université de Montréal, 2013 | 6 | 2013 |
| Patients with “dates”: Wrong for doctors but acceptable for drug companies? JC Bélisle-Pipon Bioethics Update 6 (1), 7-16, 2020 | 5 | 2020 |
| Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public B Williams-Jones, JC Bélisle-Pipon, L Ringuette, AI Cloutier, ... Autour de l’intégrité scientifique, la loyauté, et la probité : aspects …, 2016 | 5 | 2016 |
| Ethical challenges of open B Williams-Jones, JC Belisle Pipon, E Smith, R Boulanger Access Publishing. tinyurl. com/p5652d6 (Last accessed: June 8 2015.), 2014 | 5 | 2014 |
| Pharmaceutical Marketing Ethics: Ethical Standards for More Acceptable Practices JC Bélisle-Pipon Journal of Global Marketing, 2021 | 4 | 2021 |
| Mapping responsible conduct in the uncharted field of research-creation: A scoping review N Voarino, V Couture, S Mathieu-Chartier, JC Bélisle-Pipon, E St-Hilaire, ... Accountability in research 26 (5), 311-346, 2019 | 4 | 2019 |
Bryn Williams-Jones, PhDDepartment of Social and Preventive Medicine, School of Public Health, Université de MontréalVerified email at umontreal.ca
